4Accepted Oct 16, 5:00 PM ET
MapLight Therapeutics, Inc.: General counsel Hanson Kristopher sold 9,020 shares
Accepted (ET)
5:00 PM
Oct 16, 2026
Filed
Oct 16, 2026
Documents
1
Size
5.9 KB
Summary
MapLight Therapeutics, Inc.: General counsel Hanson Kristopher sold 9,020 shares
What happened
- The Form 4 reports that Hanson Kristopher, general counsel, sold 9,020 shares on Oct 15, 2026, at a weighted average price of $8.08 for total proceeds of $72,882.
Key details
- Transaction date and price: Oct 15, 2026; sale (code S); weighted average price reported $8.08; individual sale prices ranged from $7.755 to $8.3732.
- Shares owned after the transaction: the filing does not report the number of shares owned after the transaction.
- Footnotes: F1 states the shares sold were required to be sold to cover statutory tax withholding obligations on vesting restricted stock units and do not represent a discretionary sale by the reporting person. F2 explains the $8.08 is a weighted average and the reporting person will provide a breakdown of shares sold at each price on request.
- Filing date: filed with the SEC on Oct 16, 2026.
Why it may matter
- The filing indicates the sale was to satisfy tax withholding on vested restricted stock units rather than an independent discretionary sale.
- A filing does not show why the insider traded or why the company acted.